FASN-IN-7
FASN-IN-7 is a potent and orally active inhibitor of human Fatty Acid Synthase (FASN). FASN-IN-7 shows enzyme inhibition on full length FASN and the FASN KR domain with IC50 values of 28 and 54 nM. FASN-IN-7 effectively inhibits proliferation of multiple cancer cell types. FASN-IN-7 increases malonyl-CoA levels and decreases palmitate levels in tumor tissues.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 1579514-16-1
- Formel: C30H31N5O2
- Molecular Weight:493.60
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A2780 | EC50 |
>10000 nM
Compound: 34
|
Antiproliferative activity against human A2780 cells in culture medium with 10% lipid-reduced serum after 4 days in presence of palmitate by MTT assay
Antiproliferative activity against human A2780 cells in culture medium with 10% lipid-reduced serum after 4 days in presence of palmitate by MTT assay
|
[PMID: 29779975] |
| A2780 | EC50 |
13 nM
Compound: 34
|
Antiproliferative activity against human A2780 cells in culture medium with 10% lipid-reduced serum after 4 days by MTT assay
Antiproliferative activity against human A2780 cells in culture medium with 10% lipid-reduced serum after 4 days by MTT assay
|
[PMID: 29779975] |
| A549 | EC50 |
>10000 nM
Compound: 34
|
Antiproliferative activity against human A549 cells in culture medium with 10% lipid-reduced serum after 4 days in presence of palmitate by ATP-Glo assay
Antiproliferative activity against human A549 cells in culture medium with 10% lipid-reduced serum after 4 days in presence of palmitate by ATP-Glo assay
|
[PMID: 29779975] |
| A549 | EC50 |
20 nM
Compound: 34
|
Antiproliferative activity against human A549 cells in culture medium with 10% lipid-reduced serum after 4 days by ATP-Glo assay
Antiproliferative activity against human A549 cells in culture medium with 10% lipid-reduced serum after 4 days by ATP-Glo assay
|
[PMID: 29779975] |
| BT-20 | EC50 |
>10000 nM
Compound: 34
|
Antiproliferative activity against human BT20 cells in culture medium with 10% lipid-reduced serum after 4 days in presence of palmitate by ATP-Glo assay
Antiproliferative activity against human BT20 cells in culture medium with 10% lipid-reduced serum after 4 days in presence of palmitate by ATP-Glo assay
|
[PMID: 29779975] |
| BT-20 | EC50 |
10000 nM
Compound: 34
|
Antiproliferative activity against human BT20 cells in culture medium with 10% lipid-reduced serum after 4 days by ATP-Glo assay
Antiproliferative activity against human BT20 cells in culture medium with 10% lipid-reduced serum after 4 days by ATP-Glo assay
|
[PMID: 29779975] |
| HL-60 | EC50 |
120 nM
Compound: 34
|
Antiproliferative activity against human HL60 cells in culture medium with 10% lipid-reduced serum after 4 days by ATP-Glo assay
Antiproliferative activity against human HL60 cells in culture medium with 10% lipid-reduced serum after 4 days by ATP-Glo assay
|
[PMID: 29779975] |
| HL-60 | EC50 |
6310 nM
Compound: 34
|
Antiproliferative activity against human HL60 cells in culture medium with 10% lipid-reduced serum after 4 days in presence of palmitate by ATP-Glo assay
Antiproliferative activity against human HL60 cells in culture medium with 10% lipid-reduced serum after 4 days in presence of palmitate by ATP-Glo assay
|
[PMID: 29779975] |
| HT-29 | EC50 |
7940 nM
Compound: 34
|
Antiproliferative activity against human HT-29 cells in culture medium with 10% lipid-reduced serum after 4 days by ATP-Glo assay
Antiproliferative activity against human HT-29 cells in culture medium with 10% lipid-reduced serum after 4 days by ATP-Glo assay
|
[PMID: 29779975] |
| K562 | EC50 |
110 nM
Compound: 34
|
Antiproliferative activity against human K562 cells in culture medium with 10% lipid-reduced serum after 4 days by ATP-Glo assay
Antiproliferative activity against human K562 cells in culture medium with 10% lipid-reduced serum after 4 days by ATP-Glo assay
|
[PMID: 29779975] |
| K562 | EC50 |
9330 nM
Compound: 34
|
Antiproliferative activity against human K562 cells in culture medium with 10% lipid-reduced serum after 4 days in presence of palmitate by ATP-Glo assay
Antiproliferative activity against human K562 cells in culture medium with 10% lipid-reduced serum after 4 days in presence of palmitate by ATP-Glo assay
|
[PMID: 29779975] |
| LNCaP | EC50 |
66 nM
Compound: 34
|
Antiproliferative activity against human LNCAP cells in culture medium with 10% lipid-reduced serum after 4 days by ATP-Glo assay
Antiproliferative activity against human LNCAP cells in culture medium with 10% lipid-reduced serum after 4 days by ATP-Glo assay
|
[PMID: 29779975] |
| LP-1 | EC50 |
>10000 nM
Compound: 34
|
Antiproliferative activity against human LP-1 cells in culture medium with 10% lipid-reduced serum after 4 days in presence of palmitate by ATP-Glo assay
Antiproliferative activity against human LP-1 cells in culture medium with 10% lipid-reduced serum after 4 days in presence of palmitate by ATP-Glo assay
|
[PMID: 29779975] |
| LP-1 | EC50 |
10000 nM
Compound: 34
|
Antiproliferative activity against human LP-1 cells in culture medium with 10% lipid-reduced serum after 4 days by ATP-Glo assay
Antiproliferative activity against human LP-1 cells in culture medium with 10% lipid-reduced serum after 4 days by ATP-Glo assay
|
[PMID: 29779975] |
| MDA-MB-468 | EC50 |
>10000 nM
Compound: 34
|
Antiproliferative activity against human MDA-MB-468 cells in culture medium with 10% lipid-reduced serum after 4 days in presence of palmitate by ATP-Glo assay
Antiproliferative activity against human MDA-MB-468 cells in culture medium with 10% lipid-reduced serum after 4 days in presence of palmitate by ATP-Glo assay
|
[PMID: 29779975] |
| MDA-MB-468 | EC50 |
26 nM
Compound: 34
|
Antiproliferative activity against human MDA-MB-468 cells in culture medium with 10% lipid-reduced serum after 4 days by ATP-Glo assay
Antiproliferative activity against human MDA-MB-468 cells in culture medium with 10% lipid-reduced serum after 4 days by ATP-Glo assay
|
[PMID: 29779975] |
| MV4-11 | EC50 |
>10000 nM
Compound: 34
|
Antiproliferative activity against human MV4-11 cells in culture medium with 10% lipid-reduced serum after 4 days in presence of palmitate by ATP-Glo assay
Antiproliferative activity against human MV4-11 cells in culture medium with 10% lipid-reduced serum after 4 days in presence of palmitate by ATP-Glo assay
|
[PMID: 29779975] |
| MV4-11 | EC50 |
59 nM
Compound: 34
|
Antiproliferative activity against human MV4-11 cells in culture medium with 10% lipid-reduced serum after 4 days by ATP-Glo assay
Antiproliferative activity against human MV4-11 cells in culture medium with 10% lipid-reduced serum after 4 days by ATP-Glo assay
|
[PMID: 29779975] |
| NCI-H460 | EC50 |
>10000 nM
Compound: 34
|
Antiproliferative activity against human NCI-H460 cells in culture medium with 10% lipid-reduced serum after 4 days in presence of palmitate by ATP-Glo assay
Antiproliferative activity against human NCI-H460 cells in culture medium with 10% lipid-reduced serum after 4 days in presence of palmitate by ATP-Glo assay
|
[PMID: 29779975] |
| NCI-H460 | EC50 |
36 nM
Compound: 34
|
Antiproliferative activity against human NCI-H460 cells in culture medium with 10% lipid-reduced serum after 4 days by ATP-Glo assay
Antiproliferative activity against human NCI-H460 cells in culture medium with 10% lipid-reduced serum after 4 days by ATP-Glo assay
|
[PMID: 29779975] |
| NCI-H929 | EC50 |
>10000 nM
Compound: 34
|
Antiproliferative activity against human NCI-H929 cells in culture medium with 10% lipid-reduced serum after 4 days in presence of palmitate by ATP-Glo assay
Antiproliferative activity against human NCI-H929 cells in culture medium with 10% lipid-reduced serum after 4 days in presence of palmitate by ATP-Glo assay
|
[PMID: 29779975] |
| NCI-H929 | EC50 |
3720 nM
Compound: 34
|
Antiproliferative activity against human NCI-H929 cells in culture medium with 10% lipid-reduced serum after 4 days by ATP-Glo assay
Antiproliferative activity against human NCI-H929 cells in culture medium with 10% lipid-reduced serum after 4 days by ATP-Glo assay
|
[PMID: 29779975] |
| OCI-Ly1 | EC50 |
55 nM
Compound: 34
|
Antiproliferative activity against human OCI-LY1 cells in culture medium with 10% lipid-reduced serum after 4 days by ATP-Glo assay
Antiproliferative activity against human OCI-LY1 cells in culture medium with 10% lipid-reduced serum after 4 days by ATP-Glo assay
|
[PMID: 29779975] |
| OCI-Ly1 | EC50 |
6760 nM
Compound: 34
|
Antiproliferative activity against human OCI-LY1 cells in culture medium with 10% lipid-reduced serum after 4 days in presence of palmitate by ATP-Glo assay
Antiproliferative activity against human OCI-LY1 cells in culture medium with 10% lipid-reduced serum after 4 days in presence of palmitate by ATP-Glo assay
|
[PMID: 29779975] |
| PC-3M | EC50 |
25 nM
Compound: 34
|
Antiproliferative activity against human PC3M cells in culture medium with 10% lipid-reduced serum after 4 days by ATP-Glo assay
Antiproliferative activity against human PC3M cells in culture medium with 10% lipid-reduced serum after 4 days by ATP-Glo assay
|
[PMID: 29779975] |
| U-266 | EC50 |
>10000 nM
Compound: 34
|
Antiproliferative activity against human U266 cells in culture medium with 10% lipid-reduced serum after 4 days in presence of palmitate by ATP-Glo assay
Antiproliferative activity against human U266 cells in culture medium with 10% lipid-reduced serum after 4 days in presence of palmitate by ATP-Glo assay
|
[PMID: 29779975] |
| U-266 | EC50 |
10000 nM
Compound: 34
|
Antiproliferative activity against human U266 cells in culture medium with 10% lipid-reduced serum after 4 days by ATP-Glo assay
Antiproliferative activity against human U266 cells in culture medium with 10% lipid-reduced serum after 4 days by ATP-Glo assay
|
[PMID: 29779975] |
| U2932 | EC50 |
190 nM
Compound: 34
|
Antiproliferative activity against human U2932 cells in culture medium with 10% lipid-reduced serum after 4 days by ATP-Glo assay
Antiproliferative activity against human U2932 cells in culture medium with 10% lipid-reduced serum after 4 days by ATP-Glo assay
|
[PMID: 29779975] |
| U2932 | EC50 |
3020 nM
Compound: 34
|
Antiproliferative activity against human U2932 cells in culture medium with 10% lipid-reduced serum after 4 days in presence of palmitate by ATP-Glo assay
Antiproliferative activity against human U2932 cells in culture medium with 10% lipid-reduced serum after 4 days in presence of palmitate by ATP-Glo assay
|
[PMID: 29779975] |
In Vitro
FASN-IN-7 (Compound 34) (4 days) strongly inhibits cell proliferation in LRS in several cancer cell lines including A2780 (ovarian), PC3M (prostate), LNCaP (prostate), OCI-LY1 (lymphoma), MV4-11 (leukemia/lymphoma/myeloma), H460 (lung), A549 (lung), and MDA-MB-468 (breast), with EC50 values of 13, 25, 66, 55, 59, 36, 20 and 26 nM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:NCI-H460 lung xenograft-bearing mice (tumors of 300-400 mm3)[1]
-
Dosage:3 mg/kg, 10 mg/kg, 30 mg/kg
-
Administration:Oral; Twice daily; 2 days
-
Result:Increased Malonyl-CoA levels dose-dependently, reaching a plateau after 4 to 12 hours post-dose while palmitate levels decreased.
Parmacokinetics
| Species | Dose | Route | Note | Tmax | T1/2 | Cmax | AUC | F |
|---|---|---|---|---|---|---|---|---|
| Mice1 | 10 mg/kg | p.o. | 文献审核 | 2 h | 2.5 h | 2030 ng/mL | 11100 ng·h/mL | 60.6 % |
Chemical Information
-
CAS. Nr. 1579514-16-1
-
Molecular Weight 493.60
-
Formel C30H31N5O2
-
SMILES
O=C1N(C[C@H]2CN(C(C3CC3)=O)CC2)C(C4=CC=C(C5=CC=C(C6=CN(C)N=C6)C=C5)C=C4)=NC71CC7
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)